News tagged with biomed central

Related topics: breast cancer , protein

Whole genome or exome sequencing: An individual insight

Focusing on parts rather than the whole, when it comes to genome sequencing, might be extremely useful, finds research in BioMed Central's open access journal Genome Medicine. The research compares several sequencing techno ...

Jun 27, 2013
popularity 5 / 5 (2) | comments 0 | with audio podcast

Adding up autism risks

The causes of autism and autism spectrum disorder (ASD) are complex, and contain elements of both nature (genes) and the environment. New research published in BioMed Central's open access journal Molecular Autism shows ...

Oct 15, 2012
popularity not rated yet | comments 0 | with audio podcast

Breast cancer recurrence defined by hormone receptor status

Human epidermal growth factor (HER2) positive breast cancers are often treated with the same therapy regardless of hormone receptor status. New research published in BioMed Central's open access journal Breast Cancer Research shows ...

Oct 01, 2012
popularity not rated yet | comments 0 | with audio podcast

Plain packaging reduces the appeal of smoking: study

While Australia has recently passed legislation to ban logos from cigarette packages and to make plain packaging mandatory, other countries are still considering whether or not to take similar measures. New research published ...

Sep 03, 2012
popularity not rated yet | comments 0 | with audio podcast

BioMed Central

BioMed Central (BMC) is a UK-based for-profit scientific publisher specializing in open access publication. BMC publishes over 180 scientific journals, and describes itself as the first and largest open access science publisher. BMC sister companies publish the Chemistry Central and PhysMath Central journals. The Chairman is Vitek Tracz and the Publisher is Matt Cockerill.

Most titles are open access, including its flagship journals Journal of Biology, Molecular Cancer Malaria Journal, the innovative Journal of Negative Results in BioMedicine and the BMC journal series including the leading titles BMC Biology and BMC Medicine. Others are open access for the research articles portion only, such as Genome Biology, Arthritis Research & Therapy, Breast Cancer Research, andCritical Care. Some review titles, such as Current Opinion in Drug Discovery & Development are entirely subscription based. Open access content is released under the Creative Commons "Attribution" license which grants permission to reuse publications and produce derivative work.

In October 2008, it was announced that BMC, Chemistry Central, and PhysMath Central, had been acquired by Springer Science+Business Media. Previously, since its creation, the company was part of Science Navigation Group, chaired by Vitek Tracz, which also owns The Scientist (a popular science magazine—the daily news section is free access; the remainder is by subscription), Faculty of 1000 (a subscription-only current awareness service highlighting recent biological research), Global DataPoint, People's Archive and, in the past, two other companies which had previously been acquired by Springer, Images.MD (a medical image database) and Current Medicine.

In November 2008, BMC became an official supporting organisation of HIFA2015 (Healthcare Information For All by 2015).

This text uses material from Wikipedia licensed under CC BY-SA